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HPL is a proteohormone produced by the
placenta. The radio-immunological determination
is presently used mainly for supervision during
late pregnancy. There is no agreement regarding
the diagnostic or prognostic significance of
HPL during the first half of pregnancy. This
may be due to the modification of the method
of determination established for late pregnancy
necessary for a determination during early
pregnancy. The small number of results so far
obtained from examinations during early preg-
nancy may also partly be responsible.
For this reason we decided to Start by fixing the
HPL ränge for normal early pregnancies on the
basis of accurately defined groups of pregnant
women and then to check whether deviating
HPL values are to be found in women with
uterine hemorrhage during the first half of
pregnancy.
1.1 Patients
Of 195 pregnant women who came in the last six
months of 1973 to the prenatal care center on the
Obstetrical Department Berlin-Neukölln or who
had been hospitalized there, 411blood-samples
were taken from the cubital vein within the 6th
to the 20th week of pregnancy post menstruatio-
nem. By far the largest number of blood-samples
was taken early in the morning before breakfest.
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According to the clinical course of the 195
pregnancies three groups were formed.
a) Normal pregnancies: 137 pregnancies with-
out Symptoms of risk. Only such pregnant
women were included in this group for whom
the history of menstruation, clinical progress
and ultrasound diagnostic findings concerning
the stage of pregnancy coincided. This group
did not contain pregnant women having labor-
like pains, hemorrhages, who were suspected to
be diabetics (latent or manifest), having an in-
compatible Rh-constellation, or expecting twins.
No young (5j 18 years of age) or late (^30 years)
O-parae or late multiparae (^ 40 years) were in-
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cluded. All pregnancies terminated normally (37th
to 43th), aÜ infants were of normal weight (be-
tween the lOth and the 90th percentile according
to LUBCHENCO).
b) Threatened pregnancy with successful
outcome: 49 pregnant women had uterine
hemorrhages in the period between the 6th and
the 20th week of gestation, however, it was
possible to discharge these pätients from the hos-
pital after stationary treatment in a state of intact
pregnancy. No pätients with other Symptoms of
risk were accepted into this group (see above).
c) Threatened pregnancies with unsuccess-
ful outcome: 10 pregnant women hospitalized
with uterine hemorrhages had an abortion.
Pregnant women we could not categorize to
any one of the above groups (such äs diabetics)
\were not included in our investigation.
1.2 Method
• t
The blood samples were set aside for about
15 minutes at room temperature and then cen-
trifuged at 3000 rpm for 5 minutes. Until the
time of HPL determination (not later than 3
days after taking the sample) the samples were
fronen at —20°C. All samples were examined twice
at two different sensitivity regions, for evaluation
we used the individual average values of each
region showing the respectively higher accuracy
of measureinent. In the radioimmunological
determination procedure we followed LETCH-
WORTH'S method [7].
Corresponding to the HPL content of the
maternal serum in early pregnancy we used two
different sensitivity regions, where the Standard
sera for assay C covered the region from
HPL[/xg/ml]0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6
Fig. 1. Example of Standard curves (Decernber 17, 1973) of assay C and assay B. In the working scopes the Standard
curves have been graphically stressed.
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0—0.5/ig/ml and the Standard sera for assay B
covered the region from 0—1.5 /ig/ml. Assay A
contained the Standard sera from 1.0—10.0 //g/ml.
Sera with an HPL content above the region of
assay B were additionally measured together
with assay A. For assay C and B incubation
time of the Standard sera and of the patient sera
with the HPL antibody solution of the corre-
sponding sensitivity region and the antigen-
antibody complex with labeled HPL was always
one hour, whereas incubation time for assay A
was thirty minutes. Separation of bound and of
free HPL was carried out by precipitation with
absolute ethanol, the radioactivity of the bound
labeled HPL in the precipitate was measured in
a well-type y-counter (Spectroscaler III A,
PICKER Company). Measuring time was chosen
in a way that the counts per minute of the
samples containing 0.5, 1.5 or 10.0 /ig/ml amount-
ed to at least 10,000 cpm. The HPL content of
the sample to be examined was read off from
the Standard curve previously drawn.
We fixed the limits of the working scopes of
assay B and assay C at 0.18 //g/ml applying the
following procedure: From about 20 Standard
curves we found the ranges with the highest
marked rise and therefore with the best readabi-
lity (Fig. 1). The limit values, in which the
rise of the assay B Standard curve was steeper
than that of the assay C Standard curve were
near 0.18//g/ml. We used the same procedure
to fix the limit values between assay A and B,
the value we obtained was 1.3//g/ml. As an out-
come of this limitation the working scope of
assay C went up to 0.18//g/ml, of assay B from
0.18 //g/ml to 1.3//g/ml and of assay A extended
to beyond 1.3//g/ml. Out of the measured values
from different sensitivity regions we always se-
lected the value within the working scope of assay
A, B or C. Whenever the measured values lay in
different working scopes, we calculated the arith-
metic mean.
The lowest limit permitting to prove the ex-
istence of HPL by assay C is about 0.01 to
0.02//g/ml. A cross-reaction with HGH anti-
body-solution occurs in approximately 3—5%
of 0.01 //g/ml [2].
1.3 Statistical evaluation
The random samples resulting from the patients
belonging to one of the three groups and from
the weck of gestation were then arranged in an
order, where medium, maximum and minimum
values were determined [4]. Two values in the
normal groups which we considered improbable
(outliers) were eliminated.
We used the fourfold test in dealing with the
problem whether lower HPL values appear
more often in threatened pregnancies with
successful outcome than in normal pregnancies.
Starting with the 9th week of gestation, we set
up an individual fourfold test in which we
compared the number of HPL evaluation-re-
sults above and below an arbitrary value for
both groups. Since there is no value generally
accepted äs a binding limit, we chose äs limit the
minimum HPL value for a normal pregnancy
recorded by us in the particular week of gestation.
(Thus one field of our fourfold test, remained
empty at all times, since by definitionem no
value was registered below this limit for normal
pregnancies.) For statistical evaluation we used
limits of significance for the fourfold test, com-
piled on bases of the hypergeometric distri-
bution [5],
2 Results
2.1 Quality of Undings [3, 11]
2.1.1 Accuracy
The accuracy of the method depends on the degree o£
conformity between the determined ideal value and the
arithmetic mean value from many determinations of one
and the same sample.
20 repeat determinations of the HPL content of two control
sera with ideal values of 0.8//g/ml respectively of 0.15/ig/
ml were carried out every time, one of the control tests
was always run undisclosed alongside the routine de-
terminations.
a) Assay C: accuracy = 92,5%
b) Assay B: accuracy = 95%
2.1.2 Precision
The precision of a method depends on the scatter of
measured results around the arithmetic mean value of
many determinations of one and the same sample. As an
index we used the coefficient of Variation.
20 repeat determinations of the HPL content of two
conttol sera were again carried out, of these control
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samples one was run daily undisclosed alongside the
routine determinations.
a) Assay C: Coefficient of Variation = 3%.
b) Assay B: Coefficient of Variation = 3%.
2.2 Clinical results
Fig. 2 shows the HPL values found in 254
serum samples from 137 women with normal
pregnancy, and Fig. 3 shows 141 samples taken
from 49 patients with threatened pregnancies
with successful outcome for the period of the
6th to the 20th week of pregnancy. The two
measuring ranges overlap to a considerable
degree, however, from the 15th week of
pregnancy onward the tnedian of normal
pregnancy is noticeably higher than the
median of threatened pregnancies with suc-
cessful outcome. That means that greater
HPL values are found more frequently in
normal pregnancies than in threatened preg-
nancies with successful outcome; however,
no conclusion concerning the condition of
pregnancy can be drawn on the basis of a single
value.
It is also striking that minimum values for
normal pregnancies beginning with the
ninth week are considerably higher than
those for threatened pregnancies with suc-
cessful outcome.
At this point we used the fourfold test formulated
s described above. The level of significance are
shown in the last column of Tab. I. Such a
significant evaluation cannot be made before
the 9th week, because minimum values are 0
for normal pregnancies. From the 9th week of
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Fig. 2. Medi n, minimum and maximum values of HPL
determination (N = 254) for normal pregnancies from the
6th to the 20th week of pregnancy.
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Fig. 3. Median, minimum and maximum values of HPL
determination (N = 141) for threatened pregnancies with
successful outcome from the 6th to the 20th week of
pregnancy. The area of scatter for normal pregnancies is
shaded.
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Tab. I. Medi n, maximum and minimum values of HPL determinations for 137 women with normal prcgnancies (N = 254)
and 49 threatcned pregnancies with successful outcomc (N = 141) from thc 6th to thc 20th weck of gcstation. Level of
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sometimes impossible due to the composition
of random samples since the number of cases
below the minimum values for normal pregnancy
is not sufficient for the application of the fourfold
test. From the 13th to the 17th week of preg-
nancy and in the 20th week there are significant
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Fig. 4. HPL determination (n = 10) for threatened preg-
nancies with unsuccessful outcome. The dotted line
shows the minimum values of threatened pregnancies with
successful outcome. The Symbols show the time lag be-
fore curettage: A = immediately, D = 4 days later,
O = l week later, φ = 2 weeks later, Δ = 3 weeks
later.
Fig. 4 shows the values for patients who later
had an abortion (threatened pregnancy with
unsuccessful outcome). It is remarkable here
that part of these values lie within the area
which was measured also for threatened
pregnancies with successful outcome.
3. Discussion
The HPL values measured in women with
normal pregnancies coincide with the values
published by NIVEN et al. [9] and MELCHERT [8]
when a slightly modified technique is taken into
account. Our findings, however, agree also with
the values published by KELLER et al. [6], although
there are important methodological radio-immuno-
logical differences. Our values are lower than
those obtained by JANISCH et al. [5] and by YLI-
KORKALA[12] who applied different radio-immuno-
logical methods. Results show that the values in
the serum of women with normal pregnancy and
threatened pregnancies with successful outcome,
overlap tp a large extent from the 6th to the
20th week of pregnancy. However, the median
HPL values of the threatened pregnancy with
successful outcome starting with the 15th week
are markedly lower than those in normal preg-
nancies. These lower HPL values in threatened
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pregnancies with successful outcome, are possibly
an indication of a beginning placental in-
sufficiency. The frequency of dysmature children
born at term is significantly higher in women
with hemorrhages during early pregnancy than
in women without hemorrhages [10]. On the
other hand HPL values are supposed to be lower
for dysmature infants during the second half
of pregnancy [1].
Throughout the first half of gestation, threatened
pregnancies with successful outcome often show
lower HPL values than normal pregnancies.
These differences are partly significant below or
at the 5% level.
HPL values of women with uterine hemorrhage
who later have an abortion are low. Up to the
9th week of pregnancy a low or nonexistent
'»HPL content does not allow any Statement con-
cerning the further course of the pregnancy.
The later the pregnancy the stronger is the
prognostic indication of a low HPL value.
Results however, have also shown, that a single
HPL determination in a threatened pregnancy re-
sulting in the ränge of threatened pregnancies
with successful outcome does not allow the as-
sumption that the pregnancy will remain intact.
In this sense a continuous increase of HPL
can only be used very cautiously.
4. Conclusions
1. One single HPL result within the scatter area
for normal pregnancies or for threatened preg-
nancies with successful outcome is an indication
that at the time of HPL determination the placen-
tal function was intact. The result of such a
single HPL determination at best permits
only a diagnostic Statement and not a prog-
nostic one. On the other hand when one single
HPL determination shows values below the scat-
ter area for threatened pregnancies with successful
outcome it can be stated that the placental function
is out of order.
2. A careful prognostic Statement may be
made only after repeated HPL determinations.
Continuously increasing HPL values in the
scatter area for normal pregnancies or for
threatened pregnancies with successful outcome
indicate that the pregnancy may terminate with-
out disturbance. No increase or decrease of HPL
values indicates a less favorable prognosis.
The later the pregnancy (for example 15th to
20th week of pregnancy) the more one will be
inclined to draw the clinical consequence of
terminating the pregnancy when the HPL values
are markedly pathological.
3. HPL values determined after the 9th week
of pregnancy, lying considerably below the
minimum values for threatened pregnancies
with successful outcome, indicate that the
fetus is either about to die or älreädy dead.
4. In the light öf our findings the diagnostic
and prognostic importance of HPL values de-
termined before the 9th week of pregnancy in
cases of threatened pregnancy is doubtful.
Summary
To determine the purpose of the HPL area for normal
pregnancies and for checking whether deviating HPL
values are to be found in women with uterine hemorrhage
during the first half of pregnancy a well-defined group of
pregnant women was necessary. For this reason 411 blood
samples were taken from the cubital vein in the 6th to the
20th week of pregnancy post menstruationem of 195
women who in the last 6 months of 1973 came to the
prenatal care center or were admitted to the hospital.
According to the clinical course of the 195 pregnancies
three groups were formed: Normal pregnancies, threat-
ened pregnancies with successful outcome, threatened
pregnancies with unsuccessful outcome. The women
with threatened pregnancies had uterine hemorrhages in
the period between the 6th and the 20th week of gestation.
Women with other Symptoms of risk were not admitted to
any one of the groups. All samples were examined in the
sensitivity region assay C (Standard sera 0—0.5 ^ug/ml) and
assay B (0—1.5 /Jg/ml). In the radio-immunological deter-
mination we proceeded according to LETCHWORTH et al.
After measuring the rise of the Standard curves the limits of
the working scope were fixed at 0.18 ̂ ag/ml between assay B
(Fig. 1) and assay C and at 1.3//g/ml between assay B and
assay A.
To check the method we calculäted the 'äccüracy of
assay C with 92.5% and of assay B with 95%. The coefficient
of Variation (precision) of assay C and B amounted to 3%
for each one.
Fig. 2 shows the HPL values in 254 serum samples from
137 women with normal pregnancies, Fig. 3 those of 49
women with threatened pregnancies with successful out-
come in 141 samples.
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The t wo scatter areas overlap to a considerable extent;
beginning in the 15th weck of pregnancy in normal
pregnancies the median lies considerably above the
median of threatened pregnancy with successful
outcome. Minimum values for normal pregnancies
from the 9th week onward are considerably higher
than the values for threatened pregnancies with
successful outcome (Tab. I). Values for patients with
uterine hemorrhage later who had an abortion are partly
within the ränge for threatened pregnancies with
successful outcome (Fig. 4).
The results permit to draw the following most important
conclusions:
Keywords: Abortion, early pregnancy, HPL.
1. One single HPL determination with a result within the
area of scatter for normal pregnancies or for threatened
pregnancies with successful outcome is an indication
that placental function is intact (diagnostic Statement).
One single HPL determination with a result below the
area of scatter for threatened pregnancies with suc-
cessful outcome may be an indication of disturbed
placental function.
2. Continuously increasing HPL values within the area of
scatter for normal pregnancies or for threatened pregnan-
cies with successful outcome indicate that pregnancy will
take a normal course (prognostic Statement). No increase
or decrease of HPL values suggests a more unfavorable
prognosis.
Zusammenfassung
Plazentares Laktogen im Serum während der Früh-
schwangerschaft
Um an einem exakt definierten Schwangerenkollektiv den
HPL-Bereich für normale Schwangerschaften festzulegen
und um zu prüfen, ob bei Frauen mit uterinen Blutungen in
der ersten Schwangerschaftshälfte abweichende HPL-
Werte zu finden sind, wurden von 195 Schwangeren, die
in der 2. Hälfte des Jahres 1973 die Schwangerenberatung
aufsuchten oder stationär aufgenommen waren, während
der 6. bis 20. Schwangerschaftswoche post menstru-
ationem 411 Blutproben aus der Kubitalvene entnommen.
Nach dem klinischen Verlauf der 195 Schwangerschaften
wurden 3 Kollektive gebildet: Normalschwanger-
schaften, gefährdete Schwangerschaften mit gutem Aus-
gang und gefährdete Schwangerschaften mit schlech-
tem Ausgang. Die gefährdeten Schwangerschaften hatten
in dem Zeitraum von der 6. bis 20. Schwangerschaftswoche
uterine Blutungen. In kein Kollektiv wurden Schwangere
mit weiteren Risikosymptomen aufgenommen.
Alle Proben wurden in den Empfindlichkeitsbereichen
Assay C (Standardseren 0—0,5/ig/ml) und Assay B
(0—l,5^g/ml) untersucht. Bei der eigentlichen radio-
immunologischen Bestimmung wurde nach LETCH-
WORTH et al. vorgegangen. Nach Steigungsmessung der
Standardkurven wurden als Grenze der Arbeitsbereiche
die Werte 0,18;Ug/ml zwischen Assay B (Fig. 1) und
Assay C und 1,3 /Jg/ml als Grenze zwischen Assay B und
Assay A festgelegt.
Als Methodenprüfung errechneten wir eine Richtigkeit
des Assay C von 92,5% und des Assay B von 95%. Der
Variationskoeffizient (Präzision) von Assay C und B
betrug jeweils 3%.
Schlüsselwörter: Abort, Frühschwangerschaftj HPL.
Fig. 2 gibt die HPL-Werte in 254 Serumproben von 137
Normalschwangeren, Fig. 3 in 141 Proben von 49 Pa-
tientinnen mit gefährdeter Schwangerschaft mit gutem
Ausgang wieder. Die beiden Streubereiche überdecken
sich beträchtlich, der Median in der Normalschwan-
gerschaft liegt ab der 15. Schwangerschaftswoche auf-
fällig über dem Median der gefährdeten Schwanger-
schaften mit gutem Ausgang. Die Minimumwerte der
Normalschwangerschaften ab der 9. Woche liegen
bedeutend über den Minimumwerten der gefährdeten
Schwangerschaften mit gutem Ausgang (Tab. I).
Die Werte der Patientinnen mit uterinen Blutungen, die
später einen Abort erlitten, liegen teilweise in dem
Bereich für gefährdete Schwangerschaften mit gutem
Ausgang (Fig. 4).
Die Ergebnisse lassen im Wesentlichen folgende Schluß-
folgerungen zu:
1. Eine einmalige HPL-Bestimmung mit einem Ergebnis
im Streubereich für Normalschwangerschaften oder für
gefährdete Schwangerschaften mit gutem Ausgang
spricht für eine intakte Plazentafunktion (diagnostische
Aussage). Eine einmalige HPL-Bestimmung mit einem
Ergebnis unterhalb des Streubereiches für gefährdete
Schwangerschaften mit gutem Ausgang spricht für
eine gestörte Plazentafunktion.
2. Kontinuierlich ansteigende HPL-Werte im Streubereich
für Normalschwangerschaften oder für gefährdete
Schwangerschaften mit gutem Ausgang sprechen für
einen ungestörten Schwangerschaftsverlauf (prognosti-
sche Aussage). Fehlender Anstieg oder Abfall der HPL-
Werte läßt die Prognose ungünstiger erscheinen.
Resume
Lactogene placentaire du serum en d£but de grossesse
Afin de determiner la zone HPL pour les grossesses nor-
males a partir d'un groupe tres precis de femmes enceintes
et d'etudier s'il existe des valeurs HPL variables chez les
patientes ayant des hemorragies uterines durant la premiere
moitie de la grossesse, on a procede ä Pexamen de 411
prelevements sanguins de la veine cubitale effectues entre
la 6eme et la 20£me semaine de grossesse post menstru-
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ationcm sur 195 patientes re$ues en consultatino ou
hospitalisees au cours du 2eme semestre 1973. Ces 195
patientes ont ete reparties en trois groupes a la suite de
l'observation clinique: grossesses normales, grossesses
difficiles mais s'dtant bien terminoes et, enfin, gros-
sesses difficiles s'etant mal termin^es. Les grossesses
difficiles avaient fait etat d'hemorragies uterines entre la
6eme et 20£me semaine. Toute patiente ayant d'autres
symptömes de risque fut exclue des trois groupes.
Tous les prelevements furent examines dans les 2ones de
sensibilite Assay C (serum Standard 0—0,5 //g/ml) et Assay
B (0—IjS^ug/ml). La definition radioimmunologique
propre fut effectuee d'apres LETCHWORTH et al. Apres
avoir mesure l'inclinaison des courbestypes, on a pris les
valeurs 0,18/ug/ml entre Assay B (Fig. 1) et Assay C
comme limites des zones de travail et 1,3//g/ml comme
limites entre Assay B et Assay A.
Pour verification de methode nous avons calcule un
ajustement de TAssay C de 92,5% et de Assay B de 95%.
Le coefficient de Variation a ete de 3% pour Assay C
comme pour Assay B.
'«La Fig. 2 donne les valeurs HPL de 254 prelevements de
serum de 137 femmes en grossesse normale, la Fig. 3 de
141 prelevements de 49 patientes en grossesse difficile
bien terminee. Les deux domaines de dispersion se
recouvrent largement, la mediane des grossesses
Mots-cles: Avortement, debut de grossesse, HPL.
normales se situe a partir de la 15eme semaine nette-
ment au-dessus de la m£dianp des grossesses difficiles
a issue positive. Les valeurs minimales des grossesses
normales ä partir de la 9eme semaine se situent de
fa$on significative au-dessus des valeurs minimales
des grossesses difficiles bien termin^es (Tab. I).
Les valeurs des patientes avec hemorragies uterines et qui
ont eu un avortement par la suite se situent en partie
dans la zone des grossesses difficiles avec bonne
issue (Fig. 4).
Les resultats obtenus permettent de tirer pour Tessential
les conclusions suivantes:
1. Une definition HPL unique avec un resultat dans le
domaine de dispersion pour grossesses normales ou
pour grossesses difficiles bien terminees laisse supposer
une fonction placentaire intacte (declaration diagnosti-
que). Une definition HPL unique avec un resultat au-
dessous de la zone de sipersion pour grossesses dif-
ficiles avec issue positive indique une fonction pla-
centaire perturbee.
2. Des valeurs HPL croissantes de fagon continue dans le
domaine de dispersion pour grossesses normales ou
pour grossesses difficiles bien terminees temoignent
d'un deroulement de grossesse non perturbe (declava-
tion pronostic). Des valeurs HPL non croissantes ou
decroissantes fönt paraitre un pronostic moins favorable.
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